Income and antiplatelet adherence following percutaneous coronary intervention

Objective: To investigate the relation of annual household income to antiplatelet adherence following PCI. Background: Treatment with 6–12 months of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) is a Class I recommendation. Adherence to these medications is esse...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	International Journal of Cardiology. Cardiovascular Risk and Prevention
المؤلفون الرئيسيون:	Anna R. LaRosa, Gretchen M. Swabe, Jared W. Magnani
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2022-09-01
الموضوعات:	Coronary heart disease Antiplatelet therapy Social determinants
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2772487522000162

مواد مشابهة

The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events
حسب: Mansurova JA, وآخرون
منشور في: (2024-02-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
حسب: Verheugt Freek WA, وآخرون
منشور في: (2001-05-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
حسب: A. S. Tereshchenko, وآخرون
منشور في: (2019-05-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
حسب: T. M. Uskach, وآخرون
منشور في: (2020-12-01)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
حسب: Jialun Han, وآخرون
منشور في: (2023-03-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
حسب: A. N. Golosova, وآخرون
منشور في: (2020-08-01)

Thrombin generation test for evaluation of antiplatelet treatment in patients with coronary artery disease after percutaneous coronary intervention
حسب: Gelena Berezovskaya, وآخرون
منشور في: (2018-02-01)

Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy
حسب: Ji-tong Yang, وآخرون
منشور في: (2024-12-01)

Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta‐Analysis
حسب: Waqas Ullah, وآخرون
منشور في: (2024-10-01)

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD) - current state of knowledge and perspective for further research
حسب: Hubert Bochenek, وآخرون
منشور في: (2025-02-01)

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All‐Cause Mortality in Clinical Trials of Time‐Constrained Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention
حسب: John D. McClure, وآخرون
منشور في: (2020-08-01)

Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study
حسب: Carlos E. Vergara-Uzcategui, وآخرون
منشور في: (2023-04-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
حسب: S. B. Aksentiev, وآخرون
منشور في: (2021-08-01)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
حسب: Feng Huang
منشور في: (2018-06-01)

An Overview of Clinical Trials on the Duration of Dual Antiplatelet Therapy and the Scope of Novel Oral Anticoagulants Following Percutaneous Coronary Intervention
حسب: Ambukeshwar Singh
منشور في: (2024-01-01)

Dual Antiplatelet Therapy in Coronary Artery Disease
حسب: Raghav Sharma, وآخرون
منشور في: (2020-08-01)

De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
حسب: Chen Guo, وآخرون
منشور في: (2020-01-01)

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
حسب: Mattia Galli, وآخرون
منشور في: (2022-08-01)

Efficacy and Safety of Thirty-Day Dual-Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
حسب: Anastasios Apostolos, وآخرون
منشور في: (2024-01-01)

Adherence to dual antiplatelet therapy after coronary stenting: A study conducted at two Vietnamese hospitals
حسب: Anh Tien Hoang, وآخرون
منشور في: (2021-12-01)

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta‐analysis
حسب: Yuttana Wongsalap, وآخرون
منشور في: (2023-12-01)

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
حسب: Matthias Bossard, وآخرون
منشور في: (2017-11-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
حسب: T. S. Golovina, وآخرون
منشور في: (2020-09-01)

Effect of acute coronary syndrome patients’ education on adherence to dual antiplatelet therapy
حسب: Hassan El-Toukhy, وآخرون
منشور في: (2017-10-01)

Constructing a prognostic tool for predicting the risk of non-adherence to antiplatelet therapy in discharged patients with coronary heart disease: a retrospective cohort study
حسب: Jiaoyu Cao, وآخرون
منشور في: (2023-08-01)

Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease
حسب: Dong-Liang Fu, وآخرون
منشور في: (2017-01-01)

Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
حسب: Anton Håkansson, وآخرون
منشور في: (2024-07-01)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
حسب: Qiu-Ping Shi, وآخرون
منشور في: (2022-08-01)

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions
حسب: Nikolaos Pyrpyris, وآخرون
منشور في: (2025-03-01)

Antiplatelet Therapy in Acute Coronary Syndrome
حسب: I. M. Kuzmina, وآخرون
منشور في: (2022-01-01)

Safety and efficacy of shortened dual antiplatelet therapy after complex percutaneous coronary intervention: A systematic review and meta-analysis
حسب: Anastasios Apostolos, وآخرون
منشور في: (2023-05-01)

Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
حسب: Hamidreza Soleimani, وآخرون
منشور في: (2025-04-01)

Real-world analysis of characteristics and guideline adherence of antiplatelet drugs prescriptions among patients with coronary artery disease and its comorbidities: a cross-sectional study
حسب: Ting Lu, وآخرون
منشور في: (2025-08-01)

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
حسب: Fan ZG, وآخرون
منشور في: (2019-02-01)

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study
حسب: Preyanate Wilairat, وآخرون
منشور في: (2025-03-01)

Short vs Standard Duration Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with New-Generation Drug-Eluting Stents: A Meta- Analysis
حسب: Inam Ullah, وآخرون
منشور في: (2024-10-01)

Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials
حسب: Shane Parfrey, وآخرون
منشور في: (2022-10-01)

ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial
حسب: Davide Capodanno, وآخرون
منشور في: (2022-02-01)

Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention
حسب: Marco Cattaneo
منشور في: (2023-06-01)

Dual antiplatelet therapy after percutaneous coronary intervention in patients at high bleeding risk: A systematic review and meta-analysis
حسب: Yan Han, وآخرون
منشور في: (2023-08-01)